FDA Approves Epclusa for Treatment of Chronic Hepatitis C Infection

The U.S. Food and Drug Administration recently announced that Epclusa is now approved to treat adult patients with chronic hepatitis C virus (HCV), both with and without cirrhosis (advanced liver disease). Read the announcement to learn more about how this decision will widen the scope of treatment options for patients with HCV.

About Kim Rodgers

Kim Rodgers serves as a Communications Specialist at NACCHO. Her work includes promoting local health departments' best practices, as well as partner tools and resources, in infectious disease and preparedness through NACCHO's communications channels, storytelling, and outreach to various audiences.

Leave a Reply

Your email address will not be published. Required fields are marked *